The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has awarded six regional companies $2.5 million in grants as part of its inaugural Ecosystem ...

MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it is holding an Advisory Committee meeting today, at the 9th Annual ...

Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that CEO ...

For the past 38 years, classic rock tunes have floated through Lily Hall of Life Sciences, leading back to the classroom of Dennis Minchella, a biology professor at Purdue. Minchella used that music ...

Exceeds the Upper End of Guidance Range for Full-Year 2024 with Unaudited Global Revenues of Approximately $363.7 Million-- --2025 Global ARIKAYCE Revenues Expected to be Between $405 Million ...

Tyler President and CEO Lynn Moore hailed the moves—which include new chief marketing, chief legal, and chief administrative ...

Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of circular RNA medicines and unprecedented lipid nanoparticle (LNP) delivery solutions for oncology and ...

TYRA appoints urologic oncologist, Erik Goluboff, M.D., as SVP, Clinical Development to lead NMIBC- -First patient expected to be dosed in SURF302 in Q2 2025- CARLSBAD ...

August Global Partners will assist Gene Solutions in enhancing the performance of their oncology solutions by providing ...

National American University Holdings Inc (NAUH) is expected to report for 2Q. Neogen Corp (NEOG) is expected to report $-0.01 for 2Q. NexImmune Inc (NEXI) is expected to report for 3Q.

I have a hold rating on SCHG due to stretched valuations and technical signals suggesting potential consolidation or ...

These are the top universities in the United States for biology and biochemistry, based on their reputation and research in the field. Read the methodology » To unlock more data and access tools ...